Study proves new technology kills bacteria

October 20, 2011 in Diseases, Conditions, Syndromes

Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate. According to researchers, this study is one of the first to demonstrate the value of a passive infection control intervention, one that does not rely on staff or patients remembering to take action. The results will be presented on Friday, October 21 at the 2011 Annual Meeting of the Infectious Diseases Society of America in Boston.

Objects in hospital patient rooms are a potential breeding ground for bacteria that cause infections. According to Dr. Michael Schmidt, Vice Chairman of Microbiology and Immunology at the Medical University of South Carolina, and a researcher on this study, bacteria on ICU room surfaces are responsible for up to 80 percent of patient infections. The results of this study demonstrate that reducing the amount of bacteria in the patient's environment significantly lowers the risk of infection.

Hospital patients have a 1:20 chance of developing an infection, and of those who do become ill, 1:20 have chance of dying. The CDC estimates that in the U.S., hospital acquired infections kill 100,000 people and cost $45 billion annually.

The study was funded by the U.S. Department of Defense and took place at Memorial Sloan Kettering Cancer Center in New York, the Medical University of South Carolina, and the Ralph H. Johnson VA Medical Center, both in Charleston. As part of the study, common objects such as bed rails, overbed tray tables, nurse call buttons and IV poles, were replaced with antimicrobial copper versions.

Independent laboratory testing has demonstrated that when cleaned regularly, antimicrobial copper products kill greater than 99.9% of the following within two hours of exposure: MRSA, VRE, , Enterobacter aerogenes, , and E. coli O157:H7. For a complete listing of approved EPA public health claims for antimicrobial copper, please visit www.antimicrobialcopper.com. Study results are to be submitted to the U.S. Environmental Protection Agency for review and approval. Because many factors contribute to the risk of infection, individual results may vary.

Provided by Kellen Communications

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Little evidence for prediction rules for low back pain

(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...

Diseases, Conditions, Syndromes created 12 hours ago | popularity not rated yet | comments 0 | with audio podcast

New malaria test kit gives a boost to elimination efforts worldwide

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

WHO says single yellow fever shot is enough

(AP)—The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

23 dead in initiation rites in South Africa

(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.

Diseases, Conditions, Syndromes created 18 hours ago | popularity 5 / 5 (1) | comments 2

Expert questions US public health agency advice on influenza vaccines

The United States government public health agency, the CDC, pledges "To base all public health decisions on the highest quality scientific data, openly and objectively derived." But Peter Doshi, a postdoctoral fellow at Johns ...

Diseases, Conditions, Syndromes created May 16, 2013 | popularity not rated yet | comments 0


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...